BIOMAT Database Logo BIOMAT Database Logo

Recent advances in ATM inhibitors as potential therapeutic agents. 2022

Chao Dong, and Yong Wang, and Zhenlin Tu, and Jingxue Yan, and Yiqing Jiang, and Tao Lu, and Yadong Chen, and Haichun Liu
School of Science, China Pharmaceutical University, 639 Longmian Avenue, Nanjing, 211198, PR China.

ATM, a member of the PIKK-like protein family, plays a central role in responding to DNA double-strand breaks and other lesions to protect the genome against DNA damage. Loss of ATM's kinase function has been shown to increase the sensitivity of most cells to ionizing radiation. Therefore, ATM is thought to be a promising target for chemotherapy as a radiotherapy sensitizer. The mechanism of ATM in cancer treatment and the development of its inhibitors have become research hotspots. Here we present an overview of research concerning ATM protein domains, functions and inhibitors, as well as perspectives and insights for future development of ATM-targeting agents.

UI MeSH Term Description Entries
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D004268 DNA-Binding Proteins Proteins which bind to DNA. The family includes proteins which bind to both double- and single-stranded DNA and also includes specific DNA binding proteins in serum which can be used as markers for malignant diseases. DNA Helix Destabilizing Proteins,DNA-Binding Protein,Single-Stranded DNA Binding Proteins,DNA Binding Protein,DNA Single-Stranded Binding Protein,SS DNA BP,Single-Stranded DNA-Binding Protein,Binding Protein, DNA,DNA Binding Proteins,DNA Single Stranded Binding Protein,DNA-Binding Protein, Single-Stranded,Protein, DNA-Binding,Single Stranded DNA Binding Protein,Single Stranded DNA Binding Proteins
D017346 Protein Serine-Threonine Kinases A group of enzymes that catalyzes the phosphorylation of serine or threonine residues in proteins, with ATP or other nucleotides as phosphate donors. Protein-Serine-Threonine Kinases,Serine-Threonine Protein Kinase,Serine-Threonine Protein Kinases,Protein-Serine Kinase,Protein-Serine-Threonine Kinase,Protein-Threonine Kinase,Serine Kinase,Serine-Threonine Kinase,Serine-Threonine Kinases,Threonine Kinase,Kinase, Protein-Serine,Kinase, Protein-Serine-Threonine,Kinase, Protein-Threonine,Kinase, Serine-Threonine,Kinases, Protein Serine-Threonine,Kinases, Protein-Serine-Threonine,Kinases, Serine-Threonine,Protein Kinase, Serine-Threonine,Protein Kinases, Serine-Threonine,Protein Serine Kinase,Protein Serine Threonine Kinase,Protein Serine Threonine Kinases,Protein Threonine Kinase,Serine Threonine Kinase,Serine Threonine Kinases,Serine Threonine Protein Kinase,Serine Threonine Protein Kinases
D018797 Cell Cycle Proteins Proteins that control the CELL DIVISION CYCLE. This family of proteins includes a wide variety of classes, including CYCLIN-DEPENDENT KINASES, mitogen-activated kinases, CYCLINS, and PHOSPHOPROTEIN PHOSPHATASES as well as their putative substrates such as chromatin-associated proteins, CYTOSKELETAL PROTEINS, and TRANSCRIPTION FACTORS. Cell Division Cycle Proteins,Cell-Cycle Regulatory Proteins,cdc Proteins,Cell Cycle Regulatory Proteins
D025521 Tumor Suppressor Proteins Proteins that are normally involved in holding cellular growth in check. Deficiencies or abnormalities in these proteins may lead to unregulated cell growth and tumor development. Growth Suppressor Proteins,Metastasis Suppressor Protein,Metastasis Suppressor Proteins,Tumor Suppressor Protein,Protein, Metastasis Suppressor,Protein, Tumor Suppressor,Proteins, Growth Suppressor,Proteins, Metastasis Suppressor,Proteins, Tumor Suppressor,Suppressor Protein, Metastasis,Suppressor Protein, Tumor
D064007 Ataxia Telangiectasia Mutated Proteins A group of PROTEIN SERINE-THREONINE KINASES which activate critical signaling cascades in double strand breaks, APOPTOSIS, and GENOTOXIC STRESS such as ionizing ultraviolet A light, thereby acting as a DNA damage sensor. These proteins play a role in a wide range of signaling mechanisms in cell cycle control. A-T Protein,AT Mutated Protein,ATM Protein,A T Protein,Mutated Protein, AT,Protein, A-T,Protein, AT Mutated

Related Publications

Chao Dong, and Yong Wang, and Zhenlin Tu, and Jingxue Yan, and Yiqing Jiang, and Tao Lu, and Yadong Chen, and Haichun Liu
Aurora kinase inhibitors as potential anticancer agents: Recent advances.
October 2021, European journal of medicinal chemistry,
Chao Dong, and Yong Wang, and Zhenlin Tu, and Jingxue Yan, and Yiqing Jiang, and Tao Lu, and Yadong Chen, and Haichun Liu
Recent advances of Pin1 inhibitors as potential anticancer agents.
March 2024, Bioorganic chemistry,
Chao Dong, and Yong Wang, and Zhenlin Tu, and Jingxue Yan, and Yiqing Jiang, and Tao Lu, and Yadong Chen, and Haichun Liu
Recent advances in targeted protein degraders as potential therapeutic agents.
February 2023, Molecular diversity,
Chao Dong, and Yong Wang, and Zhenlin Tu, and Jingxue Yan, and Yiqing Jiang, and Tao Lu, and Yadong Chen, and Haichun Liu
Recent advances in IAP-based PROTACs (SNIPERs) as potential therapeutic agents.
December 2022, Journal of enzyme inhibition and medicinal chemistry,
Chao Dong, and Yong Wang, and Zhenlin Tu, and Jingxue Yan, and Yiqing Jiang, and Tao Lu, and Yadong Chen, and Haichun Liu
Recent advances in Hsp90 inhibitors as antitumor agents.
October 2008, Anti-cancer agents in medicinal chemistry,
Chao Dong, and Yong Wang, and Zhenlin Tu, and Jingxue Yan, and Yiqing Jiang, and Tao Lu, and Yadong Chen, and Haichun Liu
Recent advances in therapeutic agents.
January 1947, Bulletin. American Society of Hospital Pharmacists,
Chao Dong, and Yong Wang, and Zhenlin Tu, and Jingxue Yan, and Yiqing Jiang, and Tao Lu, and Yadong Chen, and Haichun Liu
Recent advances in serine protease inhibitors as anticoagulant agents.
January 2007, Current pharmaceutical design,
Chao Dong, and Yong Wang, and Zhenlin Tu, and Jingxue Yan, and Yiqing Jiang, and Tao Lu, and Yadong Chen, and Haichun Liu
Recent advances in B-RAF inhibitors as anticancer agents.
March 2022, Bioorganic chemistry,
Chao Dong, and Yong Wang, and Zhenlin Tu, and Jingxue Yan, and Yiqing Jiang, and Tao Lu, and Yadong Chen, and Haichun Liu
Recent advances in isatin hybrids as potential anticancer agents.
March 2020, Archiv der Pharmazie,
Chao Dong, and Yong Wang, and Zhenlin Tu, and Jingxue Yan, and Yiqing Jiang, and Tao Lu, and Yadong Chen, and Haichun Liu
Iminosugars as therapeutic agents: recent advances and promising trends.
September 2011, Future medicinal chemistry,
Copied contents to your clipboard!